中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
13期
58-58,60
,共2页
静脉输液%饮水疗法%羊水过少
靜脈輸液%飲水療法%羊水過少
정맥수액%음수요법%양수과소
Intravenous fluids%Drinking water treatment%Oligohydramnios
目的：探讨静脉输液与饮水疗法治疗羊水过少的临床效果。方法：2013年1月-2014年12月诊断羊水过少孕妇105例，随机分为3组，每组35例。饮水组除日常饮水外，每天3 h内饮水2000 mL，连续7 d。输液组每天静脉滴注液体2000 mL，连续7 d。对照组只接受日常饮食。所有患者在第1天、第8天分别检测羊水AFI指数和脐动脉S/D变化。结果：输液组与饮水组AFI指数明显升高，脐动脉S/D明显下降，与治疗前及对照组比较差异均有统计学意义(P＜0.01)。结论：静脉输液与饮水疗法治疗妊娠晚期羊水过少简单、有效、安全，无不良反应，值得临床推广。
目的：探討靜脈輸液與飲水療法治療羊水過少的臨床效果。方法：2013年1月-2014年12月診斷羊水過少孕婦105例，隨機分為3組，每組35例。飲水組除日常飲水外，每天3 h內飲水2000 mL，連續7 d。輸液組每天靜脈滴註液體2000 mL，連續7 d。對照組隻接受日常飲食。所有患者在第1天、第8天分彆檢測羊水AFI指數和臍動脈S/D變化。結果：輸液組與飲水組AFI指數明顯升高，臍動脈S/D明顯下降，與治療前及對照組比較差異均有統計學意義(P＜0.01)。結論：靜脈輸液與飲水療法治療妊娠晚期羊水過少簡單、有效、安全，無不良反應，值得臨床推廣。
목적：탐토정맥수액여음수요법치료양수과소적림상효과。방법：2013년1월-2014년12월진단양수과소잉부105례，수궤분위3조，매조35례。음수조제일상음수외，매천3 h내음수2000 mL，련속7 d。수액조매천정맥적주액체2000 mL，련속7 d。대조조지접수일상음식。소유환자재제1천、제8천분별검측양수AFI지수화제동맥S/D변화。결과：수액조여음수조AFI지수명현승고，제동맥S/D명현하강，여치료전급대조조비교차이균유통계학의의(P＜0.01)。결론：정맥수액여음수요법치료임신만기양수과소간단、유효、안전，무불량반응，치득림상추엄。
Objective:To explore the Treatment effect of intravenous fluids and drinking water treatment treating oligohydramnios. Methods:105 cases of pregnant women diagnosed oligohydramnios from January 2013 to December 2014 were randomly divided into three groups,with 35 cases in each group.The patients of water-drinking group drinked water 2 000 mL in 3 h daily in addition to the daily drinking water for 7 d.The intravenous fluids group were given intravenous liquid 2 000 mL every day for 7 d and the control group only accepted the daily diet.The AFI and umbilical artery S/D of all patients at the first day,eighth day were detected.Results:The AFI of patients in the water-drinking group and the intravenous fluids group increased significantly and the umbilical artery S/D obviously decreased,and there were significant differences compared with before treatment and the control group(P<0.01).Conclusion:Intravenous fluids and water therapy in the treatment of oligohydramnios in late pregnancy were simple and effective safe and had no adverse reactions,worthy of clinical promotion.
